Biopharmaceutical company focused on innovative small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders

Sectors
Healthcare
Life Sciences
First Invested
2011
Public/PIPES
Company Status
NASDAQ: ACAD
Associated Team
Paul Walker